Ratos held an Extraordinary General Meeting in Sibeliussalen, Finlandshusets konferens, Stockholm, on 14 June 2017.
Ratos informed in a press release on 11 May 2017 that Ratos's subsidiary Sophion Holding AB had entered into an agreement to divest all of its shares in Sophion Bioscience A/S to Sapphire Bioscience Holding ApS, a newly established company controlled by Thais Johansen, CEO of Sophion Bioscience A/S.
The Meeting today resolved, in accordance with the Board's proposal, to approve the transfer of all shares in Sophion Bioscience A/S to the acquisition company controlled by Thais Johansen.
The transfer is expected to be completed during June and will not generate any significant capital gain or capital loss for Ratos.
For further information, please contact:
Magnus Agervald, CEO Ratos, +46 8 700 17 00
Helene Gustafsson, Head of IR and Press Ratos, +46 8 700 17 98